Corporate investigations archive- Page 2 of 8

LifeStance Health: Company Charges Medicaid Patients Missed-Appointment and Copay Fees That Medicaid Rules Prohibit, According to Employees and Patient Complaints

LifeStance Health (LFST), a national operator of outpatient mental health clinics, routinely bills Medicaid beneficiaries for no-show fees, late-cancellation fees, and copays that are generally not allowed under Medicaid regulations, according to a Capitol Forum...

Oct 02, 2026 Read Now >

Eli Lilly: Jurisdictional Issues Raised by Seventh Circuit Threaten Eli Lilly’s Plans to File Retatrutide as a Biologic, Sources Say; Outcome Could Shorten Exclusivity Period and Allow Pharmacies to Compound Knockoff Next-Gen Weight Loss Drug

Eli Lilly (LLY) is battling with the Food and Drug Administration in court over the status of its next-generation GLP-1 weight-loss drug,...

Oct 01, 2026 Read Now >

Health Care Weekly: CMS Probes PBM Vertical Integration, Specialty Drug Pricing; FDA Issues Warning Letter Amid GLP-1 Compounding Crackdown; UNH Texas Unit Received $24.4 Million in Medicare Advantage Overpayments, Audit Finds; State AGs Dispute CMS Authority to Implement Health Care Provider Tax Rule

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • CMS probes pharmacy vertical integration, specialty drug pricing in request...

Sep 30, 2026 Read Now >

Corebridge Financial/Equitable Holdings: Merger of Equals Could Attract Close Insurance Regulator Scrutiny

Equitable Holdings (EQH) and Corebridge Financial (CRBG) seek to become one company with a combined 12 insurers and reinsurers, over 12 million customers and $1.5 trillion assets under management by the end of the...

Sep 30, 2026 Read Now >

Financials Friday: State AGs Could Target Realtors as Fees Remain Unchanged Two Years After Settlement; Kalshi Applies for Margin Trading; New York Files Second Bombshell Prediction Market Suit, This Time Against Polymarket; Subprime Auto Lender Agrees to $710 Million Settlement

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Real estate commissions remain unchanged two years after settlement,...

Sep 25, 2026 Read Now >

Health Care Weekly: Corcept Seeks Dismissal of Off-Label Marketing Whistleblower Suit; Medicare ACCESS Program to Cover More Chronic Conditions; FDA Launches Accelerated Investigational Drug Review Program; Agencies Announce Fresh Steps to Curb Animal Testing; Abbott Settles Federal Claims of Formula Contamination

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Corcept Therapeutics says alleged off-label drug promotion doesn’t...

Sep 23, 2026 Read Now >

KKR/Global Atlantic: Reinsurance Business Draws Mutuals, Traditional Life Insurers into Private Equity’s ‘Insurance as Asset Class’ Model

A vast web of reinsurance transactions has reshaped who stands behind Americans’ life insurance and retirement promises, with traditionally conservative corners of the industry increasingly dependent on the success of private equity firms and their investment strategies, a Capitol Forum...

Sep 23, 2026 Read Now >

EU Big Tech Case Tracker

This is The Capitol Forum’s Big Tech tracker, where we follow investigations and other proceedings targeting technology giants like Apple (AAPL), Alphabet (GOOG), Meta (META) and more across the EU. Here, we monitor and bring you up to date on cases launched under the bloc’s Digital...

Sep 22, 2026 Read Now >

Medline: Following FDA Warning Letter, Prior Inspections, and Recalls Related to Contamination, Company Receives FDA 483 Over Microbial Testing Practices at Mundelein Facility

In the wake of recent FDA scrutiny of microbial contamination in Medline (MDLN) products and several related recalls, FDA investigators found during a July inspection that the company has substandard processes for testing drug products for microbial contamination at its Mundelein,...

Sep 21, 2026 Read Now >

Financials Friday: Enova Abandons Federal Banking Charter; Warren Pitches Reviving Crypto Bill in a Democratic Congress; Senate Advances Trump’s CFPB Nominee; Corpay Agrees to $100 Million Deceptive Practices Fine; Zillow Loses Chicago Access in Private Listings Fight

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Enova shelves attempt to gain federal banking charter. • Warren says a...

Sep 18, 2026 Read Now >

Chemed: Families of VITAS Patients Say The Company Mismanaged the Care of Their Loved Ones, Causing Physical and Emotional Pain; Former Employees Say VITAS Misrepresented Services When Marketing and Left Patients Alone in Crises; Company Has Been Cited Hundreds of Times by Regulators for Poor Care and Holds Medicare Ratings Well Below National Average Despite Higher-Than-Average Payments

In 2024, Vitas Healthcare, the largest hospice provider in the nation and a subsidiary of Chemed (CHE), was paid by Medicare roughly 26%, or $4,000, more per patient compared with the national average to provide end-of-life care, according to an analysis of Medicare claims data for that...

Sep 18, 2026 Read Now >

Capitol Forum Analysis of August MAUDE Data

The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...

Sep 17, 2026 Read Now >

Health Care Weekly: FDA Leaders Open to Regulatory Flexibility on Psychedelics; House E&C Panel May Back Medicare Coverage for Respiratory Illness Care at Pharmacies; Patients, Plans Push for No Surprises Act Dispute Resolution Changes; CMS Can Better Screen for DME Fraud in Medicare Advantage, HHS-OIG Says

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • FDA officials say they’re open to regulatory flexibility on psychedelic...

Sep 16, 2026 Read Now >

A-CAP: South Carolina Regulator Petitions to Seize Life Insurer and Its Reinsurer Nearly Two Years After a Failed Attempt to Stop the Companies from Writing New Business

The South Carolina Department of Insurance is seeking to take control of Atlantic Coast Life Insurance Company and its reinsurer, Southern Atlantic Re, alleging that the insurers’ risk-based capital ratios “have fallen significantly below their required level for licensure and remain...

Sep 16, 2026 Read Now >

Tech/Media/Telecom Weekly: Former DOJ Official Alford Comes Out Against Cruz’s NCAA Reform Bill; Newsmax Seeks Concessions in Fox-Roku Tie-up; Tech Lobbyists Want Tariff Exemptions on Chinese Goods; China Spy Agency Views Foreign AI as a Threat; Upcoming Ruling in Collusion Case Could Clarify Bounds of Per Se Liability for Algorithmic Coordination

The TMT Weekly is a forward-looking tipsheet that covers tech policy across The Capitol Forum’s U.S. policy coverage universe, from Congress to the courts. If you have any feedback, feel free to email editorial@thecapitolforum.com. In this edition: • Congressional Outlook: Former top...

Sep 15, 2026 Read Now >

PriceLabs: Inclusion of Forward-Looking Occupancy and Pricing Data, Granular Competitor Benchmarking May Raise Antitrust Concerns

PriceLabs, a revenue management software platform for short-term rentals and hotels previously reported on by The Capitol Forum, offers competitor comparison tools on a granular level that could give rise to allegations the company engages in collusive...

Sep 14, 2026 Read Now >

Financials Friday: Lobbying for Clarity Act Erupts Ahead of Senate Vote; Warren Launches Probe Into Private Equity Ties to Insurers; Former Bancorp CFO Fined for Filing Unaudited Annual Report; Small Banks to Get Fewer Inspections; CFPB Ceases Publication of Consumer Complaints; Cannabis Shops Can’t Find a Bank

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • The crypto industry and banking groups are launching a national advertising...

Sep 11, 2026 Read Now >

Aquarian/Brighthouse: Subsidiary Relies on Controversial Tactic to Mask Financial Situation, Relieving Balance Sheet of $539 Million in Liabilities

Aquarian Holdings, which is attempting to acquire life insurer Brighthouse Financial (BHF), has a subsidiary employing a controversial accounting method that relieves its balance sheet of more than half a billion dollars in liabilities, raising questions about its...

Sep 09, 2026 Read Now >

Health Care Weekly: Pharmacists Wary of Data Sharing in CVS Caremark Settlement; FTC Touts Success of OhioHealth Probe; FDA Seeks to Speed Botanical Drug Development; CMS Announces Fraud Crackdown as Comments Close for Home Health, Hospice, DME Rule

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Independent pharmacies are concerned about FTC’s CVS Caremark settlement....

Sep 09, 2026 Read Now >

Insulet: Omnipod Users Report Persistent Leakage, Under-Delivery Problems with Insulin Devices Not Included in Prior Recall

In May, Insulet Corporation (PODD) issued a recall affecting millions of its Omnipod insulin delivery devices after some lots of the popular Omnipod 5 system, as well as the Omnipod DASH and Omnipod Eros, were found to have a small tear in the tubing just above the skin—a defect that...

Sep 08, 2026 Read Now >

Ligado Networks: Court Ruling Puts at Risk Company’s $39 Billion Lawsuit Against U.S. Government

A Federal Claims Court judge’s ruling this week will delay—and could even derail—Ligado Networks’ effort to seek $39 billion from the U.S. government for allegedly preventing the company from deploying spectrum for a cell-phone...

Sep 04, 2026 Read Now >

Financials Friday: How a Democratic President Could Boot Life Insurance Companies Out of the Federal Home Loan Bank System; New Republican Bill Targets CFPB Funding; Banks Get Into Stablecoin Business; Last Bastion of Private Listings Opposition Falls to Compass; New Jersey Kicks Kalshi Dispute to SCOTUS

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Democratic momentum for reforming the Federal Home Loan Bank system is...

Sep 04, 2026 Read Now >

The Trade Desk: Platform Offers Audience Segments Targeting Specific Health Conditions, Religious Beliefs, and Political Views

Advertising technology giant The Trade Desk (TTD) helps marketers target millions of consumers through audience data segments uploaded by third-party providers. A Capitol Forum investigation found that hundreds of these segments appear to denote potentially sensitive characteristics—...

Sep 03, 2026 Read Now >

KKR and Kuvare: KKR and Kuvare Life Insurers File Conflicting Sworn Accounts of the Same Reinsurance Deal, $542 Million Apart on the Money Set Aside for Policyholders

Kuvare Holdings-owned Guaranty Income Life Insurance Company and KKR-owned (KKR) Commonwealth Annuity and Life Insurance Company are telling their respective state regulators materially different stories about the same $542 million reinsurance deal—and they’ve been doing so for at...

Sep 02, 2026 Read Now >

Health Care Weekly: Florida AG Accuses PBMs of Price-Fixing; Acquisitions of Pending Pharma IP Should Face Antitrust Scrutiny, FTC Says; FDA Targets Online Peptide Sellers; Medicare DME Moratorium Ends; Dialysis Giants Comment on ESRD Proposal; Update on FDA Warnings About Clinical Trial Disclosures

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Prime Therapeutics, Express Scripts engaged in price-fixing, Florida AG says....

Sep 02, 2026 Read Now >

Ligado Networks: Laura Loomer Calls Out Pentagon Official Steve Feinberg Over Alleged Conflict of Interest

President Donald Trump confidante and online provocateur Laura Loomer contends there is self- dealing involved in the government’s settlement talks with Ligado Networks centered around Deputy Defense Secretary Steve...

Aug 28, 2026 Read Now >

Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation

An ongoing Capitol Forum investigation of VITAS Healthcare, a subsidiary of Chemed (CHE) and the largest hospice provider in the nation, has found that the company is enrolling patients into hospice that do not meet Medicare guidelines and recording inaccurate diagnoses to avoid scrutiny...

Aug 26, 2026 Read Now >

Super.com: Cash Advance Feature Could Expose Company to Scrutiny, Raise Consumer Protection Concerns, Experts Say

Super.com’s cash advance offering, “Super.com Cash,” resembles Earned Wage Access (EWA) products that have faced private litigation and federal enforcement, as well as scrutiny from California’s Department of Financial Protection and Innovation (DFPI) for allegedly failing to...

Aug 25, 2026 Read Now >

Maude Monthly: Insulet Omnipod Lots Outside of Recall Appear to Be Showing Same Defects; Medline Reports Thousands of Backlogged Reports; ConvaTec Subsidiary Discloses Hundreds of Deaths but Little Investigation of Their Causes

Adverse-event reports for Insulet Corporation’s (PODD) Omnipod 5 insulin pump that describe the specific defect behind two recalls earlier this spring reached an all-time monthly high in July, according to a Capitol Forum analysis of the FDA’s Manufacturer and User Facility Device...

Aug 18, 2026 Read Now >

Capitol Forum Analysis of July MAUDE Data

The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...

Aug 18, 2026 Read Now >

A Closer Look at FDA’s Next Steps Following Advisory Committee’s Recommendation to Legalize Compounding for Wellness Peptides

On July 23 and 24, an advisory committee voted to recommend that the Food and Drug Administration allow compounding pharmacies to work with six non-FDA-approved peptides— protein building blocks that proponents such as Health and Human Services Secretary Robert F. Kennedy Junior praise...

Aug 14, 2026 Read Now >

Privacy Policy: Data Brokers Begin Deletion of Over 470,000 Californians’ Personal Information as High Fines, Enforcement Expected

This month, hundreds of data brokers must begin deleting the personal information of more than 470,000 residents who registered with California’s Delete Request and Opt-Out Platform (DROP)—a first-of-its-kind online tool that could impose unprecedented fines on noncompliant companies...

Aug 14, 2026 Read Now >

KKR: KKR Life Insurer Would Have Been Taken Over by Iowa Regulators Years Ago but for a Long-Standing Accounting Maneuver Propping It Up

Concerns about the life insurance and annuity industry have focused largely on the riskiness of insurers’ investments as they’ve moved policyholder money into private, illiquid...

Aug 13, 2026 Read Now >

Chemed: Hospice Subsidiary VITAS Healthcare Overutilizing Intensive Services at Medicare’s Expense; Company Has Long History of Improper Billing Practices

As the Trump Administration continues its crackdown on hospice fraud, a Capitol Forum investigation has found that VITAS Healthcare, a subsidiary of Chemed (CHE) and the largest hospice operator in the country, may be systematically overbilling Medicare by tens of millions of dollars...

Aug 13, 2026 Read Now >

As SpeedX Gains Ground Delivering Packages for SHEIN and Temu, Sources Say It’s Cutting Corners on Safety and Pay

Four sources with direct knowledge of the daily operations at the logistics startup SpeedX raised concerns with The Capitol Forum about long hours, a lack of overtime pay, unsafe conditions, and injuries among warehouse...

Aug 12, 2026 Read Now >

Super.com’s Allegedly Deceptive Billing and Subscription Practices Draw Widespread Customer Complaints, May Raise Consumer Protection Concerns

Financial services and travel booking company Super.com may be engaging in deceptive billing and subscription tactics, according to widespread consumer complaints. The alleged practices, which resemble allegations in the federal government’s lawsuit against Uber (UBER) for its Uber One...

Aug 11, 2026 Read Now >

Aquarian/Brighthouse: Spotlight Shines on Accounting Maneuvers at Delaware-Regulated Brighthouse Reinsurer

The proposed sale of Brighthouse Financial (BHF) to Aquarian Holdings has turned the spotlight on a little-understood dynamic in the life and annuity industry, in which certain states have allowed insurers to transfer massive amounts of risk to affiliated reinsurers without any public...

Aug 07, 2026 Read Now >

Despite Strong U.S. Public Support for Banning Kids from Social Media, Big Tech is Fighting Back, Raising Issues About Age Verification and Privacy

As Australia, the UK, Canada and other countries move forward with social media bans or restrictions on users 16 and under, similar efforts in the U.S. are stalled, and Big Tech companies like Meta (META), X, Google (GOOG) and Snap (SNAP) have been lobbying against federal legislation by...

Aug 06, 2026 Read Now >

Financials Friday: New York Sues Kalshi for $36 Billion; Dodd Says Prediction Market Rules Violate Intent of Dodd-Frank; CFPB Nomination Stalls; Community Banks Line Up to Oppose ‘Skinny’ Fed Accounts for Fintechs; Former CFPB Official Tapped to Lead New Jersey Consumer Affairs Division

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • New York brings bombshell Kalshi lawsuit led by fired CFTC enforcers. •...

Jul 31, 2026 Read Now >

Figure Technologies: Balance in Non-Accrual Status Skyrockets as Figure Takes Troubled Loans onto Balance Sheet

Figure Technologies (FIGR), known for its fast-growing home equity line of credit (HELOC) origination business, reported a sharp spike in non-accrual loans on its balance sheet for the first quarter of the year, a signal that the credit quality of the loans originated by the company’s...

Jul 30, 2026 Read Now >

Pave: Compensation Benchmarking Service Provides Customers Access to Sensitive Non-Public Salary Data, Raising Questions About Potential Collusive Effect

Pave, a compensation benchmarking service, gives over 9,000 companies access to sensitive non- public salary and bonus data, a Capitol Forum investigation found. The platform’s features, including monthly data refreshes and the ability to benchmark against custom peer groups, could...

Jul 30, 2026 Read Now >

FDA’s Forthcoming Proposal Could Make Direct-to-Consumer Pharma Ads Prohibitively Long and Expensive to Run; Some Scenarios Could Make Some Current Ads Over Ten Minutes Long

An anticipated proposal from the Food and Drug Administration (FDA) could make direct-to- consumer (DTC) pharmaceutical ads so lengthy as to be cost-prohibitive, according to The Capitol Forum’s analysis and conversations with sources. In some scenarios, a stringent interpretation of...

Jul 30, 2026 Read Now >

Hims & Hers Health: FTC, Utah, and California Sue Hims & Hers Over Deceptive Billing and Privacy Practices

Today, the FTC, as well as regulators in California and Utah, filed a lawsuit against the telehealth provider Hims & Hers Health (HIMS), alleging that the company enrolled consumers in prescription subscriptions without their consent, obstructed cancellations, and shared sensitive...

Jul 29, 2026 Read Now >

Health Care Weekly: FDA Compounding Advisory Committee Votes Favorably on Six Peptides; Updates on CMS’ Implementation of SDP, Provider Tax Law; Judge Dismisses NSA Case Against HaloMD in GA; CVS Accused of 340B Spread Pricing; OpenAI Faces Unlicensed Practice of Medicine Suit; FDA 483s

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • FDA opens pathways for compounded peptides. • CMS receives comments on SDP...

Jul 29, 2026 Read Now >

Life and Annuity Industry: KKR- and Apollo-Backed Insurers, Heavily Invested in Private Credit, Have Little Cushion to Stave off Regulatory Action if Investments Take Write-Downs

A Capitol Forum analysis of statutory filings indicates that three life insurers owned by private equity giants KKR (KKR) and Apollo Global Management (APO) have remarkably little room to absorb losses on their most subjectively-valued investments before depleting capital thresholds to...

Jul 27, 2026 Read Now >

Roblox: New Advertising Policies Raise Privacy, Safety Concerns as Platform Lifts Ban on Ads for Kids Under 13

The embattled online gaming platform Roblox (RBLX) is expanding the ways brands can reach kids on the platform by lifting its self-imposed ban on showing ads to users under 13, likening its offerings to the Saturday morning cartoons of earlier...

Jul 27, 2026 Read Now >

Financials Friday: Trump’s CFPB Nominee Distances Himself From Staffing Cuts; Swing-Vote Dems Reject Clarity Act as Deadline Looms; Oregon Latest State to License Buy-Now, Pay-Later Firms; Bipartisan Push for FinCEN Reform; Celsius Founders Pay Millions for Misleading Customers Before Collapse

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Background-check questions and call for Carvana investigation arise in...

Jul 24, 2026 Read Now >

Xponential Fitness: SBA Loan Losses Exceed $9 Million

Small Business Administration (SBA) loan losses linked to franchisees of Xponential Fitness (XPOF) now exceed $9 million after more than $1.4 million in new charge-offs were recorded in the second quarter of this year, a Capitol Forum analysis of SBA loan data has...

Jul 24, 2026 Read Now >

Universal Health Services: Lawsuit Alleges Three Minors Were Sexually Assaulted While Patients at Missouri Psychiatric Hospital; One Allegation Relates to 2025 Assault, Potentially After Company Lost Insurance Coverage

A lawsuit filed in Vernon County, Missouri last month alleges that three minors were sexually assaulted during their stay at Heartland Behavioral Health, a psychiatric facility operated by Universal Health Services (UHS) in Nevada, Missouri. Importantly, one of the allegations of assault,...

Jul 23, 2026 Read Now >

Health Care Weekly: HHS Withholds More Medicaid Funds from CA and MN, Citing Suspected Fraud; House Dems Propose Bill Targeting Commercial Health Insurance Denials; Senate Votes Against Resolution to Scrap WISeR; Eli Lilly Buys Psychedelics-Focused Drugmaker; FDA Issues Letters, Asks for Input on Monitoring Infant Formula Industry; CMS Collects Public Comment on Implementing PBM Laws

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • HHS defers more than $1 billion in Medicaid payments to California and...

Jul 22, 2026 Read Now >

EDITOR'S PICKS

Read a selection of our subscriber-only news articles

Corporate investigations | RECENT ARTICLES | EDITOR'S PICKS

FILTER BY